curevac.de curevac.com

CureVac in the Media. We fight for human health. CureVac is the first company to successfully harness messenger RNA mRNA for medical purposes. The principle is promising use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases. CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA. Press Release of March 22, 2018. Press Release of February 13, 2018. Press Release of November 13, 2017.

OVERVIEW

The domain curevac.com presently has an average traffic ranking of zero (the smaller the better). We have analyzed seven pages within the web page curevac.com and found fifty-eight websites interfacing with curevac.com. There is three contacts and addresses for curevac.com to help you communicate with them. There is two social communication accounts retained by curevac.com. The domain curevac.com has been online for one thousand two hundred and sixty weeks, twenty-eight days, nineteen hours, and seventeen minutes.
Pages Crawled
7
Links to this site
58
Contacts
3
Addresses
3
Social Links
2
Online Since
Oct 2000

CUREVAC.COM TRAFFIC

The domain curevac.com is seeing a fluctuation quantities of traffic for the whole of the year.
Traffic for curevac.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for curevac.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for curevac.com

Date Range

All time
This Year
Last Year
Last Month

CUREVAC.COM HISTORY

The domain curevac.com was first filed on October 13, 2000. It was updated on October 14, 2013. This web page will expire on October 13, 2014. As of today, it is one thousand two hundred and sixty weeks, twenty-eight days, nineteen hours, and seventeen minutes old.
REGISTERED
October
2000
UPDATED
October
2013
EXPIRED
October
2014

PERIOD

24
YEARS
1
MONTHS
28
DAYS

LINKS TO DOMAIN

Werbeagentur für individuelle Markenauftritte Apollo 11

Die Sterne vom Himmel holen wollen. Design und die richtigen Emotionen. Werden Sie mit uns zur. Lassen Sie uns Ihre Marke gemeinsam in neuem Licht sehen. 17-03 VHF Edge of perfection. 16-08 SSC Arbeiten and Leben.

Boston Biotech Watch

Lab Notebook Software, Bypassed By Biologists, Poses Tough Challenge For Software Developers. By Steve Dickman, CBT Advisors. More than ten years ago, I stopped using paper notebooks for my writing and consulting work. As someone who writes and thinks for a living, this was a big transition.

Protected Blog Log in

This site is marked private by its owner. If you already have both of these, great! Larr; Back to WordPress.

Fasttranslator

Our project managers are ready to assist you with any kind of translation requests. We provide accurate translations by professional translators in all languages and all subjects. Please feel free to email us with your document for a free quotation. We will send you a no obligation quotation within an hour, during office hours. To speak to one of our project managers directly, you can also reach us by phone.

Biotech Industry, Biotech News, Biotechnology Articles FierceBiotech

Use a to require a term in results and - to exclude terms. Celgene drops option to buy Abide, bags preclinical drug. Edge plans job cuts as phase 3 brain-bleed fail routs stock.

Recent Health Articles

We bring the best health related contents. Wednesday, April 2, 2014. Practical Methods To Fade Dark Spots On Face. Practical Methods To Fade Dark Spots On Face. Friday, March 21, 2014. Colon Cancer Rates Continue To Drop. Colon Cancer Rates Continue To Drop. By now, lots of people know that sym.

WHAT DOES CUREVAC.COM LOOK LIKE?

Desktop Screenshot of curevac.com Mobile Screenshot of curevac.com Tablet Screenshot of curevac.com

CONTACTS

Curevac GmbH

Curevac GmbH

Paul-Ehrlich-Str. 15

Tuebingen, BW, 72076

DE

Curevac GmbH

Ingmar Hoerr

Paul-Ehrlich-Strasse 15

Tuebingen, BW, 72068

DE

Terrabit GmbH

Alexander Hailfinger

Gerhard-Kindler-Strasse 8

Reutlingen, Bw, 72770

DE

CUREVAC.COM SERVER

We caught that a lone page on curevac.com took six hundred and seventy-three milliseconds to download. Our crawlers could not discover a SSL certificate, so in conclusion we consider this site not secure.
Load time
0.673 secs
SSL
NOT SECURE
Internet Protocol
91.250.66.4

NAME SERVERS

ns1.nsserve.de
ns2.nsserve.de

SERVER OS

We discovered that curevac.com is employing the Apache server.

HTML TITLE

curevac.de curevac.com

DESCRIPTION

CureVac in the Media. We fight for human health. CureVac is the first company to successfully harness messenger RNA mRNA for medical purposes. The principle is promising use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases. CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA. Press Release of March 22, 2018. Press Release of February 13, 2018. Press Release of November 13, 2017.

PARSED CONTENT

The domain states the following, "We fight for human health." We observed that the web page also said " CureVac is the first company to successfully harness messenger RNA mRNA for medical purposes." It also stated " The principle is promising use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA. Press Release of March 22, 2018. Press Release of February 13, 2018. Press Release of November 13, 2017."

ANALYZE MORE WEB PAGES

Bacterial Vaginosis Treatment

Friday, February 19, 2010. Infection at some time in their life you would think that their. Would now be a general knowledge about the best way to proceed. However the fact is that many of us struggle to find a suitable. Cure with yeast infection become a recurring problem in many of. After spending far too much time visiting the doctor.

CureVape Opening Soon

Are you the store owner? .

Cureveda Homepage, COPD Research, Developing Drugs for the Treatment of Respiratory Diseases

Cureveda is focused on the discovery, development and commercialization of novel small molecule drugs for the treatment of inflammatory, autoimmune and neurological diseases.